CSIMarket Company Name, Ticker, Competitors, else..


Sangamo Therapeutics Inc   (SGMO)
Other Ticker:  
 

Sangamo Therapeutics Inc

SGMO's Fundamental analysis



Sangamo Therapeutics Inc 's sales fell by -94.79 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 1070

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 12.54 %

Sangamo Therapeutics Inc net loss decreased from $-115 millions, to $-36 millions in II. Quarter 2024,

• More on SGMO's Growth


Sangamo Therapeutics Inc
realized a net loss in trailing twelve months.

Sangamo Therapeutics Inc realized cash reduction of $ -0.2 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.09.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.96.


• More on SGMO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 29,871
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 14.69
 Tangible Book Value (Per Share $) 0.12

Sangamo Therapeutics Inc
realized net loss in trailing twelve months.

Sangamo Therapeutics Inc realized cash outflow of $ -0.2per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.09.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.96.

Sangamo Therapeutics Inc Price to Book Ratio is at 7.3 lower than Industry Avg. of 1046.11. and higher than S&P 500 Avg. of 0

• More on SGMO's Valuation

•  Market Capitalization (Millions $) 173
•  Shares Outstanding (Millions) 204
•  Employees 411
•  Revenues (TTM) (Millions $) 12
•  Net Income (TTM) (Millions $) -250
•  Cash Flow (TTM) (Millions $) -41
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 29,871
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 14.69
•  Tangible Book Value (Per Share $) 0.12

•  Market Capitalization (Millions $) 173
•  Shares Outstanding (Millions) 204
•  Employees 411
•  Revenues (TTM) (Millions $) 12
•  Net Income (TTM) (Millions $) -250
•  Cash Flow (TTM) (Millions $) -41
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 1.03
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 2.93
•  Asset Turnover Ratio (TTM) 0.09
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com